Listen to experienced operators of ketamine clinics from various parts of the country share their journey on starting and administering ketamine-assisted therapy.
Countless studies have been conducted on Ketamine-Assisted Psychotherapy (KAP) with evidence supporting it as a promising and effective treatment for patients suffering from chronic pain and medication-resistant mental health disorders, such as anxiety, depression, and PTSD. This has led to unprecedented growth in the number of private clinics that now offer KAP. Today, an estimated 1,200 to 1,500 ketamine clinics operate in the U.S., compared to 60 clinics in 2015.
Despite KAP entering the mainstream, as with most new interventions, it’s considered high risk for a myriad of reasons, including:
- The FDA lacks oversight of the process since the medication is used off-label.
- Multiple existing federal and state laws and regulations apply to clinics, including who can own and operate them.
- There isn’t much data available on the long-term effects or potential risks.
- There is no clear consensus on best practices – including who qualifies for treatment, optimal dosing, and the type of medical care that should be offered concurrently.
- There are conflicting opinions about who should participate on a patient’s treatment team before, during, and after KAP (including who should administer the infusion).
Eric And David Rahn, R&A PSYINS
Daniel McQueen, MA, Co-Founder/Executive Director, Medicinal Mindfulness
Daniel McQueen, MA, is a Psychedelic Specialist, Psychedelic Therapy Educator, Activist, Author of Psychedelic Cannabis, and the co-founder and Executive Director of the Center for Medicinal Mindfulness, one of the first legal psychedelic plant medicine centers in the United States. Daniel specializes in using Cannabis-Assisted Psychedelic Therapy and Ketamine-Assisted Psychedelic Therapy. Since Colorado legalized natural psychedelics in 2022 for personal use, Daniel leads his team in providing psilocybin and DMT support services through his non-profit, the Medicinal Mindfulness Foundation, and is spearheading an effort to make Extended-State DMT experiences accessible through his DMTx program. Daniel has significant experience guiding clients with severe mental health struggles such as PTSD, as well as growth-oriented experiences that support creative problem-solving, personal growth, and spiritual exploration.
Daniel holds a master’s degree in Transpersonal Counseling Psychology from Naropa University (2012) and has over twenty years of experience as a psychedelic professional. He is the lead trainer in the center’s psychedelic therapy training program, Psychedelic Sitters School. His work through Psychedelic Sitters School and with psychedelic cannabis has created an internationally recognized movement of practitioners across the United States and Canada, Mexico, Europe, Australia, and Israel.
Justin Rome Lubin, JD, CKF. Founder/Executive Director, Perspective Wellness
A graduate of the University of California, Santa Cruz, and the University of California, Hastings College of Law, Justin is a former attorney, social entrepreneur, husband, and father of five, and a psychedelic facilitator with robust experiences in life, loss, and love. Justin is the creative and driving force behind Perspective Wellness’ efforts to make accessible psychedelic therapies a reality in Wisconsin and beyond. With years of experience as a litigator and transaction attorney, and almost a decade of experience serving as COO of a large community mental health clinic, Justin brings a unique and passionate voice to the conversation about psychedelic accessibility models, finance, operations, and compliance. And with his depth of experience facilitating hundreds of journey sessions with a diverse clientele, Justin is an expert in ketamine facilitation best practices, methods, and protocols.
Mark Holland, Chief Executive Officer, Choose Your Horizon
Mark is a serial entrepreneur in the consumer health space. He is currently the CEO of Choose Your Horizon, a 15-state telehealth business delivering affordable and responsible ketamine therapy protocols to patients with treatment-resistant anxiety, depression, and other conditions.
Prior to that, Mark built and sold a nutraceutical and clinical trial business to a Fortune 500 CPG entity. He also has a keen interest in sustainable business practices and has led the sustainable business network in YPO as chairman in the past.
Christina Thomas, President & Founder, MY Self Wellness
As President and Founder of MY Self Wellness, Christina Thomas leads management and operations for the Ketamine Clinic—ensuring employees, partners, and customers alike experience the highest level of support and assistance. Christina has over a decade of experience in the hospitality and management industries and received her undergraduate degree from Florida Gulf Coast University (FGCU).
She is on a mission to share the restorative benefits of Ketamine with anyone suffering from mental, emotional, and physical distress. Opening its doors one week before the COVID-19 lockdown of 2020, MY Self Wellness stands as a beacon of hope and healing to anyone suffering from mental health issues.
RSVP To Reserve Your Spot